Agios Pharmaceuticals, Inc. (AGIO) Financials

AGIO Assets vs Liabilities

DateAssetsLiabilities
2024-03-31 849.7 million 105.8 million
2023-12-31 937.1 million 126.1 million
2023-09-30 1.0 billion 120.4 million
2023-06-30 1.1 billion 120.9 million

AGIO Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2024-03-31 -100.0 million 9.2 million
2023-12-31 -72.7 million 13.8 million
2023-09-30 -79.5 million 9.1 million
2023-06-30 -66.7 million 11.7 million

AGIO Net Income

No data available :(

AGIO Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2024-03-31 - - 68.3 million
2023-12-31 776.9 million - 72.0 million
2023-09-30 872.4 million - 75.5 million
2023-06-30 946.9 million - 78.9 million

AGIO Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2024-03-31 56.8 million
2023-12-31 55.9 million
2023-09-30 55.8 million
2023-06-30 55.6 million

AGIO Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2024-03-31 141000 68.6 million 31.0 million -
2023-12-31 234000 76.1 million 35.3 million -
2023-09-30 17.9 million 81.8 million 25.8 million -
2023-06-30 3000 68.9 million 30.4 million -

AGIO Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2024-03-31 8.2 million 627000
2023-12-31 7.1 million 2.0 million
2023-09-30 7.4 million 633000
2023-06-30 6.7 million 1.1 million

AGIO

Price: $34.34

52 week price:
19.80
35.50

Earnings Per Share: -6.31 USD

P/E Ratio: -5.89

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 44002

Ebitda: -88.5 million

Market Capitalization: 2.0 billion

Links: